In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Window's Still Open, Just not Wide Open

Executive Summary

The IPO window for device companies remains open, but not to the astonishing valuations of the first half of the year.

You may also be interested in...



Pressure On Medtech Companies High, And Recalls Frequent, Amidst COVID-19

Medical device manufacturers are operating in what may be the industry’s most challenging business and regulatory environment in recent history, attorneys Bill McConagha and Pamela Amaechi argue in this guest article.

Execs On The Move: Medtech Bosses Drop Titles To Make Way For New Execs

Biolife4D CEO dropped president title and Cryo-Cell International co-chief executive officer dropped director title to open spots for new executives; Essex Bio-Technology deputy managing director was promoted to executive director; and more.

Coronavirus Update: Novavax Launches Phase III Trial In UK As Virus Surges Back

Novavax aims to recruit 10,000 subjects in the UK, and will include a flu vaccination co-administration for some participants.

Topics

UsernamePublicRestriction

Register

PS122308

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel